
CAS 95716-98-6
:Trier par
Degré de pureté (%)
0
100
|
0
|
50
|
90
|
95
|
100
5 produits concernés.
Eplerenone EP Impurity F Potassium salt
CAS :Formule :C24H31O7·KCouleur et forme :White To Off-White SolidMasse moléculaire :431.51 39.109,11α-Epoxy-17-hydroxy-7α-(methoxycarbonyl)-3-oxo-17α-pregn-4-ene-21-carboxylic Acid Potassium Salt
CAS :Couleur et forme :NeatEplerenone Hydroxyacid Potassium Salt
CAS :Produit contrôlé<p>Applications A metabolite of Eplerenone. Used in combination therapy for treatment of cardiovascular disorders.<br>References Staessen, J., et al.: J. Endocrinol., 91, 457 (1981), de Gasparo, M., et al.: J. Pharmacol. Exp. Ther., 240, 650 (1987), MacFadyen, R., et al.: Cardiovasc. Res., 35, 30 (1997),<br></p>Formule :C24H31O7·KCouleur et forme :Off-White To Light YellowMasse moléculaire :470.60Eplerenone-methyl-d3 Hydroxyacid Potassium Salt
CAS :Produit contrôlé<p>Applications A labelled metabolite of Eplerenone. Used in combination therapy for treatment of cardiovascular disorders.<br>References Staessen, J., et al.: J. Endocrinol., 91, 457 (1981), de Gasparo, M., et al.: J. Pharmacol. Exp. Ther., 240, 650 (1987), MacFadyen, R., et al.: Cardiovasc. Res., 35, 30 (1997),<br></p>Formule :C24D3H28KO7Couleur et forme :NeatMasse moléculaire :473.615Eplerenone hydroxyacid potassium salt
CAS :<p>Eplerenone is a drug that belongs to the class of drugs known as selective mineralocorticoid receptor antagonists. It is a prodrug that is metabolized in vivo to its active form, eplerenone acid. Eplerenone inhibits the binding of aldosterone to its receptors in the kidney. Eplerenone hydroxyacid potassium salt has been shown to have stereochemical purity of >98% and no detectable process-related impurities or experimental impurities. High-performance liquid chromatography (HPLC) methods have been used to characterize this drug substance and confirm that it has an average particle size 10 micrometers with no particles > 150 micrometers.</p>Formule :C24H31KO7Degré de pureté :Min. 95%Masse moléculaire :470.6 g/mol



